SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Wealth Alliance

Wealth Alliance boosted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,083 shares of the exchange traded fund’s stock after purchasing an additional 173 shares during the quarter. Wealth Alliance’s holdings in SPDR S&P Biotech ETF were worth $368,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF in the fourth quarter worth $29,000. Avior Wealth Management LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares during the period. Tidemark LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares during the period. Quintet Private Bank Europe S.A. acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at $40,000. Finally, Bank of Jackson Hole Trust acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at $43,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $91.70 on Friday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The company has a market cap of $6.99 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The firm has a fifty day moving average of $91.36 and a 200-day moving average of $95.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.